(Q34243503)

31 July 2017

1 reference

title

Leukemias related to treatment with DNA topoisomerase II inhibitors (English)

1 reference

31 July 2017

1 reference

Felix CA

1

1 reference

31 July 2017

publication date

1 May 2001

1 reference

31 July 2017

published in

Pediatric Blood Cancer

1 reference

31 July 2017

volume

36

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

525-535

1 reference

The secondary leukemias: challenges and research directions

31 July 2017

cites work

1 reference

21 January 2018

1 reference

Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins

21 January 2018

1 reference

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia

21 January 2018

1 reference

Myeloid neoplasia in children treated for solid tumours.

21 January 2018

1 reference

Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia

21 January 2018

1 reference

Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9;11 translocation

21 January 2018

1 reference

21 January 2018

1 reference

Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia

21 January 2018

1 reference

Secondary leukaemia after epipodophyllotoxins

21 January 2018

1 reference

Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer

21 January 2018

1 reference

Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols

21 January 2018

1 reference

Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours

21 January 2018

1 reference

MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3).

21 January 2018

1 reference

Acute lymphoblastic leukemia occurring as a second malignant neoplasm in childhood: report of three cases and review of the literature

21 January 2018

1 reference

Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias

21 January 2018

1 reference

21 January 2018

1 reference

Second malignancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed irradiation: a Pediatric Oncology Group study.

21 January 2018

1 reference

When good enzymes go bad: conversion of topoisomerase II to a cellular toxin by antineoplastic drugs

21 January 2018

1 reference

Epipodophyllotoxins in the treatment of childhood cancer

21 January 2018

1 reference

Teniposide: overview of its therapeutic potential in adult cancers

21 January 2018

1 reference

Incidence of secondary acute myelogenous leukemia after treatment of childhood acute lymphoblastic leukemia

21 January 2018

1 reference

Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors

21 January 2018

1 reference

Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associated MLL translocation breakpoints

21 January 2018

1 reference

DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis

21 January 2018

1 reference

Topoisomerase II inhibitors induce DNA double-strand breaks at a specific site within the AML1 locus

21 January 2018

1 reference

Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia

21 January 2018

1 reference

Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans' cell histiocytosis in Italian and Austrian-German populations.

21 January 2018

1 reference

LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society.

21 January 2018

1 reference

Acute leukemia in association with Langerhans cell histiocytosis

21 January 2018

1 reference

High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors.

21 January 2018

1 reference

Substrates of human hepatic cytochrome P450 3A4.

21 January 2018

1 reference

Mechanism of action of antitumor drug etoposide: a review

21 January 2018

1 reference

Role of the semi-quinone free radical of the anti-tumour agent etoposide (VP-16-213) in the inactivation of single- and double-stranded phi X174 DNA.

21 January 2018

1 reference

Association of CYP3A4 genotype with treatment-related leukemia

21 January 2018

1 reference

Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations

21 January 2018

1 reference

Infant cancer in the U.S.: histology-specific incidence and trends, 1973 to 1992.

21 January 2018

1 reference

Panhandle PCR for cDNA: a rapid method for isolation of MLL fusion transcripts involving unknown partner genes

21 January 2018

1 reference

A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias

21 January 2018

1 reference

The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene

21 January 2018

1 reference

Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias

21 January 2018

1 reference

Analysis of the murine All-1 gene reveals conserved domains with human ALL-1 and identifies a motif shared with DNA methyltransferases

21 January 2018

1 reference

Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product

21 January 2018

1 reference

An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes

21 January 2018

1 reference

MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25)

21 January 2018

1 reference

Self-fusion of the ALL1 gene. A new genetic mechanism for acute leukemia

21 January 2018

1 reference

Resistance of t(4;11) (MLL-AF4 fusion gene) leukemias to stress-induced cell death: possible mechanism for extensive extramedullary accumulation of cells and poor prognosis.

21 January 2018

1 reference

Induction of topoisomerase I cleavage complexes by 1-beta -D-arabinofuranosylcytosine (ara-C) in vitro and in ara-C-treated cells

21 January 2018

1 reference

21 January 2018

1 reference

The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein

21 January 2018

1 reference

Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP

21 January 2018

1 reference

Acute promyelocytic leukemia following treatment of non-Hodgkin's lymphoma

21 January 2018

1 reference

The peptide repeat domain of nucleoporin Nup98 functions as a docking site in transport across the nuclear pore complex

21 January 2018

1 reference

Involvement of 11p15 and 3q21q26 in therapy-related myeloid leukemia (t-ML) in children. Case reports and review of the literature

21 January 2018

1 reference

Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia

21 January 2018

1 reference

The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9

21 January 2018

1 reference

Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer

21 January 2018

1 reference

Acute nonlymphoblastic leukemia in children treated for acute lymphoblastic leukemia with an intensive regimen including teniposide

21 January 2018

1 reference

Allogeneic Bone Marrow Transplantation for Therapy-Related Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Long-Term Study of 70 Patients—Report of the French Society of Bone Marrow Transplantation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MPO.1125

1 reference

31 July 2017

1 reference